 |
|
Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion
Su Young Moon, Kwan Hyuk Cho, Se Joon Woo, Sung Pyo Park, Yong-Kyu Kim
Korean J Ophthalmol. 2018;32(1):29-37. Published online 2018 Jan 25 DOI: https://doi.org/10.3341/kjo.2016.0134
|
|
Citations to this article as recorded by
 Comparison of Intravitreal Dexamethasone Implant and Bevacizumab Injection for Branch Retinal Vein Occlusion with Macular Edema According to Macular Perfusion
Seung Joon Lee, Chang Wook Choi
Journal of Retina.2020; 5(2): 135. CrossRef Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients
Wungrak Choi, Sung Eun Park, Hyun Goo Kang, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sungchul Lee, Gong Je Seong, Chan Yun Kim, Min Kim
British Journal of Ophthalmology.2019; 103(10): 1380. CrossRef Comparison of dexamethasone intravitreal implant with intravitreal anti-VEGF injections for the treatment of macular edema secondary to branch retinal vein occlusion
Kaibao Ji, Qinglin Zhang, Man Tian, Yiqiao Xing
Medicine.2019; 98(22): e15798. CrossRef Combination therapy and co-delivery strategies to optimize treatment of posterior segment neurodegenerative diseases
Alicia Arranz-Romera, Sergio Esteban-Pérez, David Garcia-Herranz, Alba Aragón-Navas, Irene Bravo-Osuna, Rocio Herrero-Vanrell
Drug Discovery Today.2019; 24(8): 1644. CrossRef A Comparison of Three Intravitreal Modalities of Branch Retinal Vein Occlusion Macular Edema
Han Song, Hee Jun Song, Ji Ho Yang, Do Gyun Kim
Journal of the Korean Ophthalmological Society.2018; 59(9): 834. CrossRef
|